Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) Target Price at $29.11

Aspen Aerogels, Inc. (NYSE:ASPN) has been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $29.11.

A number of brokerages recently commented on ASPN. Piper Sandler lowered their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Barclays lowered their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Finally, Roth Mkm lowered their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $11.50 on Monday. The stock has a market cap of $943.13 million, a price-to-earnings ratio of 1,150.65 and a beta of 2.14. Aspen Aerogels has a 52 week low of $10.75 and a 52 week high of $33.15. The company’s 50-day moving average price is $13.14 and its 200 day moving average price is $19.90. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds have recently modified their holdings of ASPN. Point72 Hong Kong Ltd purchased a new position in shares of Aspen Aerogels during the 2nd quarter worth about $84,000. Quent Capital LLC purchased a new position in Aspen Aerogels in the third quarter valued at approximately $118,000. Point72 DIFC Ltd purchased a new position in Aspen Aerogels in the second quarter valued at approximately $121,000. nVerses Capital LLC raised its holdings in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares during the period. Finally, Public Employees Retirement Association of Colorado purchased a new stake in shares of Aspen Aerogels during the second quarter valued at approximately $145,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.